Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Dermatologic 3Other solid neoplasm 1Other neoplasm 1Head & Neck 1Gastrointestinal 1

Conditions

Advanced Malignant Neoplasm 1

Interventions

Cyclophosphamide 13Biopsy 13fludarabine phosphate 9Whole-Body Irradiation 9Surveys and Questionnaires 9Peripheral Blood Stem Cell Transplantation 9Busulfan 9Polymerase Chain Reaction 7Mycophenolic Acid 7Early Intervention, Educational 7Tacrolimus 6Gene Expression Profiling 6Educational Status 6Colposcopy 6Carboplatin 6fludarabine 5Paclitaxel 5Microarray Analysis 5Methotrexate 5Methods 5Melphalan 5Immunohistochemistry 5Epoetin Alfa 5Decitabine 5Cyclosporine 5Cisplatin 5Celecoxib 5Antilymphocyte Serum 5Aminolevulinic Acid 5Sulindac 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Sunscreening Agents × Other neoplasm × Clear all
NCT01867294 2020-01-09

Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab

Academic and Community Cancer Research United

Phase 2 Completed
19 enrolled 9 charts
Other neoplasm

Advanced Malignant Neoplasm

Data powered by HemOnc (CC BY 4.0) Colophon âš¡